AB-004 (Akso Biopharmaceutical)

N/A

Report date: 2024/01/19 16:29:34

Base Information

Drug NameAB-004 (Akso Biopharmaceutical)

Drug Alias NameAB-004AB004

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionTumor necrosis factor ligand superfamily member 13 inhibitorsB-cell activating factor receptor inhibitorsInterleukin-11 inhibitors

TargetsTumor necrosis factor ligand superfamily member 13B-cell activating factor receptorInterleukin-11

Therapy Area/IndicationsRenal fibrosisIdiopathic Pulmonary FibrosisLiver Cirrhosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAkso Biopharmaceutical Inc

China Registration ClassN/A

Develop Information

Active CompaniesAkso Biopharmaceutical Inc

Inactive CompaniesN/A

Active IndicationsRenal fibrosisIdiopathic Pulmonary FibrosisLiver Cirrhosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A